CTOs on the Move

HealthMyne

www.healthmyne.com

 
The HealthMyne Quantitative Imaging Decision Support (QIDS)® software platform and its Rapid Precise Metrics (RPM)™ functionality transform multiple clinical decision support workflows by combining quantitative imaging metrics with relevant patient information.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

HealthMyne raised $15M on 08/01/2018

Similar Companies

Aural Analytics

We build applications that use speech and fine motor to detect subtle changes in brain health. We are rooted in neuroscience with an award winning, first to market technology platform that turns the devices we use every day into objective brain health monitors.

Mills-Peninsula Health Services

Mills-Peninsula Health Services is a Burlingame, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Triple Ring Technologies

Triple Ring Technologies is a Newark, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ayurvedic Center Inc

Ayurvedic Center Inc is a Hollywood, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Schulman Associates Institutional Review Board

Since 1983, Schulman has provided the research community with IRB review services of the highest quality. In establishing the IRB, our founders sought to promote clinical research by helping to safeguard the rights and welfare of clinical research subjects. Schulman’s team of dedicated professionals seeks to provide timely, quality services based on the foundation of respect for persons, beneficence and justice. Through continuous quality improvement and rigorous training on human subject protection, Schulman provides thorough, ethical, responsive and thoughtful review of research studies. By combining impeccable review standards, savvy industry insight, responsive customer service and innovative technological solutions, Schulman creates a review experience that goes beyond the expected. We look forward to continued collaboration with our colleagues in North America and around the world as we uphold our mission to protect the rights and welfare of clinical research subjects.